Professor & Head, Department of Geriatric Medicine, AIIMS New Delhi
ID: DMC-13924
Delhi Medical Council (DMC) & Medical Council of India (MCI)
Dr. Prasun Chatterjee is Professor in the Department of Geriatric Medicine at the All India Institute of Medical Sciences (AIIMS), New Delhi. A leading authority on healthy longevity, memory clinics, dementia care, and geriatric polypharmacy, he oversees clinical guidance on senior health and longevity.
Geriatric Medicine, Healthy Aging, Dementia & Alzheimer's Care, Polypharmacy & Fall Prevention
18+ Years Academic Geriatrics & Clinical Research
Professor, Department of Geriatric Medicine, AIIMS, Ansari Nagar, New Delhi
“Comprehensive Geriatric Assessment (CGA) and Frailty Biomarkers in Predicting Functional Decline and Hospital Readmission in Community-Dwelling Elderly”
Institution: All India Institute of Medical Sciences (AIIMS), New Delhi
Landmark MD dissertation validating multi-domain frailty scoring, clinical sarcopenia indices (Grip strength, gait speed, DEXA), and systematic polypharmacy deprescribing protocols in outpatient memory clinics.
Dr. Chatterjee reports zero commercial conflicts of interest or pharmaceutical relationships.
Verified for medical accuracy, safety guidelines, and clinical evidence.
Senior HealthAge-related muscle wasting (sarcopenia) and osteopenia are not inevitable consequences of aging. Discover evidence-based clinical protocols for progressive resistance training, dietary leucine-rich protein distribution, balance vestibular training, and home fall-risk reduction.
Senior HealthcareOsteoporosis is a systemic skeletal disorder characterized by low bone mineral density (BMD) and microarchitectural deterioration of bone tissue, leading to bone fragility and heightened fracture risk. Explore the cellular biology of osteoclast/osteoblast remodeling, dual-energy X-ray absorptiometry (DEXA) T-score interpretation, FRAX fracture risk algorithms, anti-resorptive vs. anabolic bone medications, and progressive resistance loading.
Senior HealthcareDementia is an umbrella clinical syndrome characterized by progressive cognitive decline severe enough to interfere with independent daily functioning. Explore the neuropathological hallmarks of Alzheimer's Disease (extracellular amyloid-beta plaques and intracellular hyperphosphorylated tau neurofibrillary tangles), cognitive screening instruments (MoCA, Mini-Cog), reversible pseudo-dementias, and disease-modifying monoclonal antibody therapies.
Senior HealthcareOsteoarthritis (OA) is the most common chronic joint disease globally, characterized by the progressive degradation of hyaline articular cartilage, subchondral bone sclerosis, osteophyte formation, and low-grade synovial inflammation. Explore the biomechanical and enzymatic pathophysiology of cartilage wear, Kellgren-Lawrence radiographic grading, evidence-based non-pharmacological exercise therapy, and surgical joint arthroplasty.
Senior HealthcareSarcopenia is the age-related loss of skeletal muscle mass, strength, and neuromuscular function that drives frailty, fall risks, and loss of functional independence in seniors. Review EWGSOP2 diagnostic criteria (handgrip dynamometry, chair rise test, DEXA appendicular lean mass), optimal per-meal protein distribution (30–40g), and progressive resistance training protocols.
Senior HealthcareBenign prostatic hyperplasia (BPH) is the non-malignant adenomatous proliferation of the prostate transition zone, affecting over 70% of men over age 60. Review obstructive vs. irritative urinary symptoms, the International Prostate Symptom Score (IPSS), PSA evaluation, alpha-1 blockers, 5-alpha reductase inhibitors, and minimally invasive surgical therapies.
Senior HealthcarePolypharmacy—the concurrent use of 5 or more prescription medications—affects over 40% of older adults, significantly increasing the risk of adverse drug reactions, cognitive decline, falls, and prescribing cascades. Review the AGS Beers Criteria for potentially inappropriate medications, anticholinergic burden, and structured deprescribing protocols.
